Page last updated: 2024-10-23

bepridil and Marburg Disease

bepridil has been researched along with Marburg Disease in 1 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeWald, LE1
Dyall, J1
Sword, JM1
Torzewski, L1
Zhou, H1
Postnikova, E1
Kollins, E1
Alexander, I1
Gross, R1
Cong, Y1
Gerhardt, DM1
Johnson, RF1
Olinger, GG1
Holbrook, MR1
Hensley, LE1
Jahrling, PB1

Other Studies

1 other study available for bepridil and Marburg Disease

ArticleYear
The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease.
    The Journal of infectious diseases, 2018, 11-22, Volume: 218, Issue:suppl_5

    Topics: Animals; Bepridil; Calcium Channel Blockers; Chlorocebus aethiops; Disease Models, Animal; Female; M

2018